NetworkNewsBreaks

TuesdayNov 24, 2020 2:09 pm

NetworkNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Begins Strategic Greater Bay Area Expansion

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced its entry into an agreement with three preschools (the First and Fourth Preschools and the Children's Center) of Guangzhou Development District Talent Work Group of Augmented Reality Immersive Classes (“ARIC”). According to the update, the move marks the beginning of Blue Hat's strategic expansion in the Guangdong -Hong Kong-Macao Greater Bay Area (the “Greater Bay Area”). “I am pleased with Blue Hat's cooperation with three preschools in Guangzhou. At present, we have…

Continue Reading

TuesdayNov 24, 2020 1:51 pm

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Featured in Stock2Me Podcast

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, was featured in InvestorBrandNetwork’s (“IBN”) latest episode of its Stock2Me Podcast. Stock2Me Podcasts feature a fascinating array of companies and individuals, many of whom are revolutionizing business practices within their respective markets. AZRX president and CEO James Sapirstein joins IBN’s Stuart Smith in the latest episode to discuss how AzurRx is working to redefine the standard of care for patients living with cystic fibrosis and chronic pancreatitis. “AzurRx Bio has been around for five years. … Our main product, MS1819, is being studied in…

Continue Reading

TuesdayNov 24, 2020 1:24 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Brain Cancer Drug During Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. During the broadcast, CNS Pharmaceuticals CEO John Climaco explains that the company has recently submitted an investigational new drug (“IND) application to the U.S. Food & Drug Administration (“FDA”) for its brain cancer drug, Berubicin. Climaco also discusses CNSP’s intent to begin Phase 2 trials of the drug during Q1 2021. The Phase 2 trial is designed to analyze the efficacy of Berubicin in treating patients with Glioblastoma…

Continue Reading

TuesdayNov 24, 2020 1:04 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Diamond Equity Research Emerging Growth Invitational

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will participate at the Diamond Equity Research Emerging Growth Invitational taking place virtually on Dec. 1, 2020. According to the update, Genprex’s executive vice president and COO, Michael Redman, will virtually deliver a company overview to investors followed by a guided question and answer session. Redman’s presentation is scheduled to begin at 11:30 a.m. ET on Dec. 1. Interested parties may visit https://www.nnw.fm/BjNia to register for the webinar. A live audio webcast and archive of the conference presentation…

Continue Reading

TuesdayNov 24, 2020 12:36 pm

NetworkNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) to Expand UV350 Offering to New Market Verticals in Europe

Siyata Mobile (NASDAQ: SYTA, SYTAW), a business-to-business (“B2B”) global vendor of next-generation cellular solutions, today announced its entry into a distribution agreement with pei tel Communications GmbH, a distributor based in Germany, for its Siyata UV350. According to the update, pei tel’s distribution countries include Germany, Austria, Switzerland, Belgium, Netherlands, and Luxembourg. “We are extremely excited to partner with pei tel to expand our Siyata UV350 offering to new market verticals in Europe,” said Marc Seelenfreund, CEO of Siyata Mobile. “This is a fantastic opportunity for Siyata to engage with new European clientele in an effort to become a leading…

Continue Reading

TuesdayNov 24, 2020 12:11 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Present at H.C. Wainwright Virtual Mining Conference

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, today announced that its president and CEO, Mark S. Chalmers, will present at the H.C. Wainwright Mining Conference slated to be held on Nov. 30 and Dec. 1, 2020. Chalmers’ presentation is scheduled to begin at 3:00 p.m. ET on Monday, Nov. 30, where he will provide an update on the company, including progress on its uranium and rare earth element (“REE”) initiatives. Chalmers will also be available to participate in one-on-one meetings with investors registered to attend the conference via Zoom. Interested parties may visit https://www.nnw.fm/KyUwD…

Continue Reading

TuesdayNov 24, 2020 11:43 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Receives Official Government Approval to Export Medical Cannabis

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organically grown cannabis, has received an export certificate from Health Canada. This official certification allows TGOD to finalize its initial shipment of medical cannabis. That shipment is headed to Europe, where it will undergo stability testing in Germany. This testing is the final step in The Green Organic Dutchman’s efforts to commence commercialization, which is scheduled to begin in 2021. "This is an important milestone as we get ready to begin the international shipping of our certified organically grown medical cannabis products,” said interim TGODF CEO Sean…

Continue Reading

TuesdayNov 24, 2020 11:17 am

NetworkNewsBreaks – Innovative Payment Solutions Inc. (IPSI) Engages with Planet Hunny to Expand Reach to US Latino Community

Innovative Payment Solutions (OTCQB: IPSI), a U.S.-based fintech company building a 21st century digital payment solution, today announced the launch of a joint marketing venture with social marketing company Planet Hunny Inc. According to the update, the venture will leverage Planet Hunny’s influencers in order to reach specific Latin-American markets to expand Innovative’s access to Hispanic users while also working to introduce customers in Innovative’s network to Planet Hunny. “We see a tremendous opportunity for Innovative to reach new users, including millennials and Gen Z, by entering into this relationship,” said William Corbett, president and CEO of Innovative. “Planet Hunny’s…

Continue Reading

TuesdayNov 24, 2020 10:50 am

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Schedules 2020 Annual General Meeting, Announces Record Revenue, Gross Profit for Q3 2020

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, on Monday announced the schedule for its 2020 annual general meeting. According to the update, iClick will hold the meeting at 9:00 a.m. (Hong Kong time) on December 23, 2020, in Hong Kong, China. In addition, iClick today released unaudited financial results for the third quarter ended September 30, 2020. “We have delivered record revenue and gross profit in the third quarter of 2020, as China continues to recover from the coronavirus pandemic,” said Jian “T.J.” Tang, iClick's chief executive officer and co-founder.…

Continue Reading

TuesdayNov 24, 2020 10:45 am

NetworkNewsBreaks — MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Outlines Investor Initiatives, Announces Conference Presentation

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agricultural biotech company focused on developing and commercializing natural biological solutions for high-value crops, announced its upcoming investor awareness initiatives today. In addition, the company will be conducting a presentation today at the Future of Food Investment Conference; one-on-one investor meetings are also being scheduled for next week. According to the announcement, MustGrow’s key programs and catalysts include testing of its biopesticide, which is formulated to stop Fusarium wilt TR4, a disease pathogen ravaging the $25 billion global banana industry; filing of key patents and progress on proof-of-concept data related to a biological…

Continue Reading